Side-by-side financials for DERM and NVS. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | DERM | NVS |
|---|---|---|
| Market cap | - | $293.70 B |
| US-listed rank | - | #46 |
| Revenue (latest FY) | $61.86M | - |
| Net income (latest FY) | -$11.43M | - |
| Net margin | -18.5% | - |
| SEC filings | 210 | 947 |
Full pages: Journey Medical Corp and Novartis AG, or browse the full rankings.